Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders |
Soluna Holdings, Inc (SLNH)
|
Add to portfolio |
|
|
Price: |
$11.89
| | Metrics |
OS: |
35.7
|
M
| |
|
|
Market cap: |
$424
|
M
| |
|
|
Net debt:
|
$7.91
|
M
| |
|
|
EV:
|
$432
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($14.9)
|
M
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
Revenues | 28.5 | 14.3 | 0.6 | 6.6 | 7.1 | 7.1 | 6.3 | 8.8 |
Revenue growth | 99.0% | 2310.9% | -90.9% | | 0.1% | 11.5% | -27.9% | 5.1% |
Cost of goods sold | 14.3 | 3.5 | 0.4 | 2.2 | 2.2 | 2.7 | 2.5 | 3.3 |
Gross profit | 14.3 | 10.8 | 0.2 | 4.3 | 4.8 | 4.3 | 3.8 | 5.5 |
Gross margin | 50.0% | 75.6% | 31.9% | 66.2% | 68.2% | 61.2% | 60.7% | 62.6% |
Selling, general and administrative | 47.9 | 19.9 | 1.8 | 2.7 | 3.1 | 3.5 | 3.8 | 3.6 |
Research and development | | | | 1.4 | 1.1 | 1.2 | 1.5 | 1.3 |
General and administrative | 19.2 | 9.2 | | | | | | |
EBITA | -32.0 | -2.9 | -1.6 | 0.3 | 0.6 | -0.4 | -1.5 | 0.6 |
EBITA margin | -112.2% | -20.2% | -276.0% | 3.9% | 8.3% | -5.1% | -23.2% | 6.4% |
Amortization of intangibles | 9.5 | 1.6 | | | | | | |
EBIT | -41.5 | -4.5 | -1.6 | 0.3 | 0.6 | -0.4 | -1.5 | 0.6 |
EBIT margin | -145.4% | -31.2% | -276.0% | 3.9% | 8.3% | -5.1% | -23.2% | 6.4% |
Pre-tax income | -108.4 | -6.3 | -1.5 | 0.3 | 0.6 | -0.4 | -1.5 | 0.7 |
Income taxes | -1.3 | 0.0 | -0.3 | 0.0 | 0.0 | 0.0 | 1.4 | 0.0 |
Tax rate | 1.2% | | 21.5% | | 1.0% | 2.4% | | |
Net income | -205.7 | -11.6 | 1.9 | 0.3 | 0.6 | -0.4 | -2.8 | 0.7 |
Net margin | -720.7% | -81.2% | 327.1% | 4.9% | 8.2% | -5.1% | -44.7% | 8.4% |
|
Diluted EPS | ($13.73) | ($0.98) | $0.20 | $0.03 | $0.06 | ($0.06) | ($0.54) | $0.14 |
Shares outstanding (diluted) | 15.0 | 11.8 | 9.6 | 9.6 | 9.3 | 6.0 | 5.3 | 5.5 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|